Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on June 10, 2025
HPQ Silicium, Novacium et Pragma Industries concluent un accord de coopération industrielle et commerciale pour la production d’hydrogène vert à l’aide de la technologie METAGENE™
GlobeNewswire
·
June 10, 2025
MONTRÉAL et LYON, France, 10 juin 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de …
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 10, 2025
LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive …
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease
GlobeNewswire
·
June 10, 2025
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease AstraZeneca exercises option to license the first candidate from the IBD joint research program for further development and commercialization …
InStride Redefines Workforce Development Through Strategic Expansion
GlobeNewswire
·
June 10, 2025
LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education and skilling solutions, today announced continued growth, accelerated by its new and transformative approach to workforce development. Recently named by TIME …
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
GlobeNewswire
·
June 10, 2025
MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard) MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage …
Skyharbour Intersects High-Grade Uranium in Significant 42 m Step Out Hole ML24-15 which Returned 4.74% U3O8 over 1.5 m within 6.4 m of 1.50% U3O8 at Moore Project
GlobeNewswire
·
June 10, 2025
Vancouver, BC , June 10, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the remaining assay results from its late 2024 diamond drilling program at its 100% owned, 35, …
Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity
GlobeNewswire
·
June 10, 2025
WEST VALLEY CITY, Utah, June 10, 2025 (GLOBE NEWSWIRE) -- Nusano today announced it has successfully enriched gadolinium-160 (Gd-160) to 99.2% purity, a significant milestone demonstrating the company’s in-house stable isotope production program. “ …
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
GlobeNewswire
·
June 10, 2025
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Kaleris Acquires Locus Software
GlobeNewswire
·
June 10, 2025
ATLANTA, June 10, 2025 (GLOBE NEWSWIRE) -- Kaleris, a global provider of leading supply chain optimization technology, today announced the acquisition of Locus Software, an operations management system for carriers. The acquisition expands Kaleris’ …
Brunswick Exploration Once More Outlines a New, Major Dyke at Mirage
GlobeNewswire
·
June 10, 2025
MONTREAL, June 10, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report a further six drill results from the Winter 2025 program at its Mirage Project. The Mirage Project is located in …
Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases
GlobeNewswire
·
June 10, 2025
MRT-8102, a highly selective NEK7-directed molecular glue degrader (MGD) developed to treat inflammatory conditions linked to NLRP3, IL-1β, and IL-6 dysregulation, expands Monte Rosa’s clinical I…
Pharvaris Announces Annual Meeting of Shareholders
GlobeNewswire
·
June 10, 2025
ZUG, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
GlobeNewswire
·
June 10, 2025
LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that it is partnering with the Association of Pulmonary Advanced Practice Providers (APAPP) to bring new educational …
BEN Secures $3.5 Million Line of Credit
GlobeNewswire
·
June 10, 2025
WILMINGTON, Del., June 10, 2025 (GLOBE NEWSWIRE) -- Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, today announced it has entered into a $3.5 million line of credit agreement with Corps Capital …
NVIDIA Powers Europe’s Fastest Supercomputer
GlobeNewswire
·
June 10, 2025
HAMBURG, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- ISC -- NVIDIA today announced that the JUPITER supercomputer, powered by the NVIDIA Grace Hopper™ platform, is the fastest in Europe — delivering a more than 2x speedup for high-performance computing and …
XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology
GlobeNewswire
·
June 10, 2025
Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization Agreement with Grifols, a global …
HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration
GlobeNewswire
·
June 10, 2025
Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its …
NETSOL Secures Product Expansion with UK Brokerage Charles and Dean
GlobeNewswire
·
June 10, 2025
ENCINO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, has announced that Charles and Dean, one of the United Kingdom's leading independent …
मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि
GlobeNewswire
·
June 10, 2025
बेंगलुरु, भारत, June 10, 2025 (GLOBE NEWSWIRE) -- बेंगलुरु स्थित बायोटेक्नोलॉजी कंपनी RenaissThera प्राइवेट लिमिटेड ने अपने मोटापा रोधी दवा कार्यक्रम के तहत ग्लूकोज़-डिपेंडेंट इंस्युलिनोट्रॉपिक पोलिपेप्टाइड रिसेप्टर (GIPR) को लक्ष्य करते हुए एक महत्वपूर्ण …
SEON Launches AI-Powered Anti-Money Laundering Suite, Enhancing its Comprehensive Command Center for Risk Management
GlobeNewswire
·
June 10, 2025
AUSTIN, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- SEON, a global leader in digital fraud prevention, announced the launch of its expanded Anti-Money Laundering (AML) Compliance suite, a significant step in the company’s evolution from fraud prevention to a …